Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.

With over three decades of global medtech experience, he will lead the next phase of growth and innovation for the company. Das joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.

He was earlier working as Director- Diagnostics Systems at BD, where he had the complete P&L & Strategic responsibility for BD's microbiology and women's health / cancer business vertical. His role involved creating a long term strategic plan, driving investment, leading marketing, sales & issue based advocacy, building an organisation and kick starting locally relevant product development.

Avnish Mehra, Vice Chairman - Everstone Capital commented, “Probir's exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”

Integris has built a strong market access and commercialisation capability in India, South East Asia and key strategic markets in Europe, Middle East and LatAm, through which the company distributes its own innovative products and solutions and those of its partners.